Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced the completion of a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties, expanding the Company's ...

SACRAMENTO, CA, UNITED STATES, April 28, 2026 /EINPresswire.com/ — Lunai Bioworks, Inc. (Nasdaq: LNAI) (the “Company”) today announced that it has postponed its Special Meeting of Stockholders (the ...

Lunai Bioworks, Inc. (NASDAQ: LNAI) ("Lunai"), an AI-driven drug discovery company, and Geneial, Inc., a precision medicine data infrastructure and patient engagement company, today announced that ...

Ginkgo Bioworks has been focusing on developing its artificial intelligence capabilities to enhance its cell programming platform. The company's results, however, have been underwhelming, with sales ...

View Ginkgo Bioworks Holdings, Inc. Class A DNA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at what’s going on. What To Know: Ginkgo Bioworks shares appear to be getting ...

Ginkgo Bioworks Holdings, Inc. (NASDAQ:DNA) shares are trading lower Friday after the company posted worse-than-expected fourth-quarter results and issued disappointing guidance. The company reported ...

Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The ...

Ginkgo Bioworks is a cell programming specialist that has partnered with many big companies. It is in a very early stage, but has a lot of promising opportunities in the long run. A big part of the ...